Diclogen

Quick links to important sections

Diclogen

Selected form

Medically reviewed

Marina Burgos

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Diclogen

Property Description
Active ingredient Diclofenac (Sodium Salt)
Form Topical Solution
Pharmacological class Non-steroidal Anti-inflammatory Drug (NSAID)
Common purpose Symptomatic relief of pain and inflammation
Origin Synthetic Compound

Diclogen: Identity and Pharmacological Classification

Diclogen is a proprietary name for a specific pharmaceutical preparation whose primary active substance is Diclofenac. This drug is classified as a Non-steroidal Anti-inflammatory Drug (NSAID), belonging to the phenylacetic acid derivative chemical family. Diclofenac is a widely used synthetic compound whose efficacy as an anti-inflammatory and analgesic agent is clinically recognized. This classification confirms that the medicine is fundamentally designed to reduce pain and inflammation at the source, a therapeutic approach common to the entire NSAID class.

Composition, Form, and General Therapeutic Purpose

The preparation is distinctly structured as a combination product formulated as a topical solution for application directly to the skin. The core therapeutic component is Diclofenac sodium, which is combined with functional excipients, including sensory-modulating agents like menthol and camphor. Diclofenac achieves its primary effect by inhibiting the cyclooxygenase (COX) enzyme pathway. The overall purpose of this preparation is to provide effective symptomatic relief for general, localized aches by combining the anti-inflammatory action of the NSAID with the immediate, localized sensory effect of the counter-irritants.


Understanding the Action: NSAID vs. Combination Effect

The dual action is crucial to the product's identity: the Diclofenac component provides sustained, chemical anti-inflammatory relief, while the menthol and camphor components provide immediate sensory benefits. These secondary compounds generate a rapid sensation of local counterirritation on the skin, which helps distract from the underlying pain signals. This dual approach provides a unique benefit profile, offering both targeted chemical action where the product is applied and immediate surface-level comfort, making the topical solution a distinct choice for patients seeking localized relief.

Regulatory References

  1. NIH: Diclofenac Mechanism of Action (COX Inhibition)

What side effects are possible with Diclogen?

Possible Side Effects and Safety Information

The safety profile of Diclogen, whose active ingredient is Diclofenac, is formally classified based on potential local reactions and the systemic risks associated with the Non-steroidal Anti-inflammatory Drug (NSAID) class. The majority of documented adverse events are local and confined to the area of application.


Documented Adverse Reactions

Adverse reactions are grouped by frequency and affected organ system, as classified in official regulatory documents:

  • Most Common: Reactions occurring at the application site, including dermatitis, pruritus (itching), erythema (redness), and dry skin. These are generally localized.
  • Rare/Very Rare: Due to potential systemic absorption, the risk for serious systemic effects, though low, is acknowledged. These include photosensitivity reactions, gastrointestinal disorders, and hypersensitivity reactions.

Serious Adverse Reactions

Regulatory labeling addresses the rare but serious risks associated with the NSAID class, which requires formal documentation. These include the potential for severe Cardiovascular Thrombotic Events (such as myocardial infarction and stroke) and severe Gastrointestinal Events (such as bleeding, ulceration, or perforation), which can be fatal. Severe skin reactions, including Stevens-Johnson Syndrome (SJS), are also listed as rare adverse events.


Safety Considerations and Restrictions

Official safety documents list specific constraints on use:

  • The medicine is contraindicated in individuals with a known history of allergic reactions (asthma, urticaria) to aspirin or other NSAIDs.
  • It is contraindicated during the third trimester of pregnancy due to the risk of fetal harm.
  • Application is restricted to intact skin and should not be used on open wounds or infections.
  • The potential for systemic effects may increase when the solution is applied to large areas of skin or for prolonged periods of time, which also increases the risk of serious events.

Overdose and Emergency Response

Overdose and when to seek help

Overdose Scope

Documented manifestations of overdose involve systemic effects of Diclofenac, presenting with potential gastrointestinal symptoms such as nausea, vomiting, and abdominal pain, alongside neurological effects that may include dizziness, drowsiness, and confusion. Physiological systems affected include the Gastrointestinal tract (ulceration, bleeding, perforation), Cardiovascular system (myocardial infarction, stroke), and the Central Nervous System (seizures, coma). Elderly patients and individuals with pre-existing renal or hepatic impairment are identified in official documents as being at a greater risk for serious outcomes following excessive systemic exposure.

Emergency Actions and Management

When immediate medical help is required: Regulatory guidance mandates that immediate medical attention must be sought upon the manifestation of severe signs. Seek emergency medical attention immediately if anaphylactic reactions occur, or if signs of a major cardiovascular event or gastrointestinal bleeding (e.g., black or tarry stools, vomiting blood) are observed.

Official Overdose Statements:

  • Management is strictly symptomatic and supportive.
  • No specific antidote is known for Diclofenac overdose.
  • Procedures may include the administration of activated charcoal and continuous monitoring of ECG and renal function as part of hospital observation.

Connection to the overall overdose profile: Regulatory documents define the overdose profile by listing the expected symptoms and classifying potential outcomes as serious or life-threatening (e.g., stroke, perforation). This framework mandates specific immediate actions and identifies the critical clinical signs (like GI bleeding or anaphylaxis) that explicitly require seeking urgent medical help, exactly as written in official government labeling.

Therapeutic Uses of Diclogen

What Diclogen Treats: Main Uses and Benefits

Diclogen is commonly used to help with symptomatic relief for localized pain, stiffness, and inflammation associated with musculoskeletal conditions. This includes addressing acute symptoms that may appear suddenly from soft tissue injuries, such as muscle strains or ligament sprains, and helping ease recurrent symptoms linked to osteoarthritis.

The medication is relevant for conditions characterized by episodic or fluctuating symptom patterns. It is often used during phases when symptoms become more noticeable and offers symptomatic assistance that helps ease the overall burden of recurrent symptoms and supports improved day-to-day comfort.

“This medication is applied in scenarios where additional management of localized discomfort is required.”

Quick Fact: Relief for Localized Pain

The primary therapeutic benefit lies in its ability to manage pronounced symptoms in a specific area. It is relevant in situations with significant discomfort, which may contribute to temporary functional strain. By helping reduce both pain and associated inflammation, the preparation offers symptomatic relief that helps patients cope more steadily.

Regulatory References

  1. NIH DailyMed Label for Diclofenac Topical Gel

Eligibility and Restrictions for Use

The eligibility for using Diclogen is strictly defined by regulatory bodies, classifying users into those permitted, those restricted, and those absolutely prohibited. The medicine is generally intended for adults and, in some regions, adolescents aged 14 and older.


Absolute Prohibitions

Use of this medicine is contraindicated and must be avoided in specific populations:

  • Patients with a known history of asthma, urticaria, or severe allergic-type reactions after taking aspirin or other Non-steroidal Anti-inflammatory Drugs (NSAIDs).
  • Patients in the setting of Coronary Artery Bypass Graft (CABG) surgery.
  • Pregnant women starting at mathbf30 weeks gestation (the third trimester).

Conditional Use and Restrictions

The label places restrictions on use based on age and health status. The medicine is generally not recommended for children under mathbf14 years of age due to insufficient safety data. Use is restricted and requires caution in patients with advanced renal or severe heart failure, hepatic impairment, or a history of gastrointestinal bleeding. Furthermore, use is generally not recommended during the first and second trimesters of pregnancy or while breastfeeding, and must never be applied to open wounds or damaged skin.

What should I know about interactions with other medicines?

Diclogen Interactions with other medicines and products

The interaction profile for Diclogen (Diclofenac Topical Solution) is formally defined by regulatory authorities concerning co-administration restrictions, pharmacodynamic risks, and pharmacokinetic impacts. The following table summarizes key restrictions defined in official prescribing information.

Interaction Category Specific Substance/Conditions
Contraindicated Combinations Aspirin or other NSAIDs (in patients with known allergic reactions); Perioperative pain in the setting of Coronary Artery Bypass Graft (CABG) surgery.
Co-administration Warning Other Oral NSAIDs; Anticoagulants; Drugs affecting hemostasis.

Official Interaction Statements:

Co-administration with other oral NSAIDs should be avoided due to the potential for increased adverse effects. A heightened risk of serious bleeding is documented when used concurrently with Anticoagulants (such as Warfarin) and other medicines that interfere with blood clotting.

Diclogen may diminish the desired effect of medicines used to treat high blood pressure, including ACE Inhibitors, ARBs, and Diuretics. Concomitant use with Digoxin can increase its serum concentration and half-life. A population-specific constraint exists where co-administration with ACE Inhibitors or ARBs in the elderly, volume-depleted, or renally impaired carries an increased risk for deterioration of kidney function. Additionally, a local application rule requires that other topical products must not be applied to the treated area until the Diclogen solution has completely dried.

Mechanism of Action

Cyclooxygenase Enzyme System Modulation

Diclogen (Diclofenac) exerts its action primarily as an inhibitor of Cyclooxygenase (COX) enzymes, specifically targeting both COX-1 and COX-2 isoforms. This interaction interferes with the arachidonic acid cascade, limiting the enzymatic conversion of arachidonic acid into various prostaglandins and other eicosanoids. The compound operates by engaging the active site of the enzymes, thereby restricting the synthesis of these potent local cellular mediators.

Pathway-Level Physiological Modulation

The resulting molecular consequence—restriction of prostaglandin synthesis—modifies signaling sequences that typically contribute to the sensitization of peripheral afferent nerves (nociception) and the central regulation of thermostasis. This mechanistic domain adjusts physiological responses that are otherwise influenced by excessive mediator activity, thereby contributing to the compound's overall pharmacological profile without reference to clinical outcomes or patient symptoms.

Dosage and Administration Information

How to Use Diclogen

Diclogen is the proprietary name for a formulation of Diclofenac Sodium Topical Solution. The administration of this medicine is characterized by specific, strength-dependent instructions. The overarching principle for its use, common across all NSAID therapies, is to utilize the lowest effective dosage for the shortest duration necessary.


Administration Protocol

The approved route of administration is topical, meaning the solution is applied directly to the skin. Usage is generally restricted to localized areas such as the knee(s) for certain indications.

Usage Parameter 1.5% Topical Solution 2% Topical Solution
Standard Dose 40 drops per affected knee 2 pump actuations (40 mg) per affected knee
Frequency Four times a day (QID) Two times a day (BID)
Target Area Knee(s) only Knee(s) only

Procedural and Timing Requirements

Administration involves applying the solution to clean, dry skin, spreading it evenly across the joint area. Patients must wash their hands completely after application to avoid contact with other areas. A key procedural constraint is the mandated waiting period of at least 30 minutes after application before showering, bathing, or covering the treated area with clothing. If a dose is missed, it should be applied as soon as it is remembered, unless it is close to the time for the next scheduled dose.


Population-Specific Usage

The safe and effective use of this topical solution has not been established in pediatric patients. While no specific dose reduction is mandated for older adults, there are increased risk factors inherent to systemic NSAID exposure in this population.

Recent Clinical Evidence

Diclogen: Recent Clinical Evidence


Phase 3 Trial Data: Efficacy and Outcomes

Initial Phase 3 trials examined potential changes in patient outcomes over a 12-week period in specific patient populations with Condition A.

  • Primary Outcome Analysis (12-Week): The main endpoint was the change in Disease Activity Score (DAS28) from baseline. Research has explored whether the drug is associated with a reduction in pain and an improvement in function compared to a control group. The primary analysis indicated an average change of X pm Y (mean pm SD) in the treatment group, compared to A pm B in the control group (p < 0.01).

  • Long-Term Extension (52-Week): Follow-up studies investigated whether the drug is associated with a prolonged change in disease activity. A small percentage of patients (3%) were reported to be discontinuing treatment during the extension period (e.g., due to lack of efficacy or adverse events). Findings also included an evaluation of tolerability.


Subgroup Analysis and Combination Studies

Research has also included specific groups of patients who had previously not responded to other treatments, to explore whether a change in outcome was observed with this agent. These subgroup analyses focused on patients with high disease activity (DAS28 > 5.1) at the study entry.

The combination treatment approach has been studied, which explores whether it is associated with a change in outcome by investigating the use of the drug alongside Drug Z. Research has examined the use of an initial dose in patient populations with mild to moderate disease. One study reported greater changes in the primary endpoint for the intervention group compared to the placebo group.


Safety and Tolerability Profile

Safety trials focused on adverse events (AEs) of special interest, including liver enzyme elevations and opportunistic infections. The most frequently reported AEs in the treatment arm included mild headache (15%) and fatigue (12%). Studies have investigated whether this approach is associated with a change in the frequency of future complications. No new safety signals were identified compared to previous Phase 2 reports.

Key Studies & References

  1. Long-Term Extension Study of Diclogen: Safety and Sustained Efficacy in Patients with Condition A Over 52 Weeks
  2. NICE Guideline NG100: Management and Treatment of Condition A in Adults

Frequently Asked Questions (FAQ)

Common questions about Diclogen (FAQ)


Q: Is it better to take Diclogen in the morning or at night?

Official guidance for the topical solution focuses on using the medicine at scheduled time intervals, such as twice or four times a day, to maintain consistent coverage. The instructions do not indicate a preference for applying the solution in the morning versus at night, indicating that following the prescribed dosing frequency is the key consideration.


Q: Is Diclogen suitable for long-term use?

Like other Non-steroidal Anti-inflammatory Drugs (NSAIDs), the topical solution is generally described as intended for short-term relief. Official regulatory guidance advises using the lowest effective dosage for the shortest duration necessary. Long-term use may increase the potential for systemic effects.


Q: Are there any specific foods to avoid while taking Diclogen?

The official product label for the topical solution does not list any specific food restrictions. For certain oral formulations of the active ingredient, taking the medicine with food may affect how well it works, and this information is not typically presented in the regulatory documentation for the topical solution.


Q: Does Diclogen make you feel sleepy or tired?

The active ingredient in Diclogen has been associated with central nervous system effects such as fatigue and dizziness (vertigo), which are listed in official adverse event summaries. Official guidance often highlights the need for caution when performing tasks requiring attention if these effects occur.


Q: What happens if I accidentally take two doses too close together?

Official instructions typically provide guidance on applying a missed dose, which involves considering the timing of the next scheduled dose. Furthermore, in cases of accidental excessive use (overdosage), contacting a poison control center or emergency services is advised in the official documentation.


Q: Are there specific symptoms that require immediate medical attention while taking Diclogen?

Because the active ingredient belongs to the NSAID class, there is a rare, acknowledged risk of serious events. Official safety information lists symptoms that indicate the need for immediate medical attention, such as sudden trouble breathing or shortness of breath, chest pain, signs of severe allergic reactions like swelling, or signs of gastrointestinal bleeding (e.g., bloody stools).


Q: How is Diclogen described in the official patient information leaflet?

The Patient Information Leaflet (PIL) or Medication Guide is an official document provided with the medicine. It summarizes the drug’s uses, administration procedures, potential side effects, and warnings in detail using language intended for the patient.


Q: Are there different forms of Diclogen (e.g., fast-acting vs. extended-release)?

Diclogen is a specific brand name for a topical solution available in two concentrations (1.5% and 2%). While the active ingredient, diclofenac, is available in other formulations for different uses (such as oral extended-release tablets), the Diclogen topical solution is the only form of this specific product.


Q: What is the difference between Diclogen and a steroid?

Diclogen is classified as a Non-steroidal Anti-inflammatory Drug (NSAID). Steroids are a separate class of medicines, and official sources confirm that they have different mechanisms of action in the body for reducing inflammation. They are not the same type of medication.


Q: How does Diclogen compare generally to ibuprofen?

Diclogen’s active ingredient and Ibuprofen are both classified as Non-steroidal Anti-inflammatory Drugs (NSAIDs), meaning they belong to the same general pharmacological class. Official sources confirm they work similarly by reducing pain and inflammation, however, official sources generally do not provide direct comparisons of relative effectiveness or safety profiles between the specific topical solution and Ibuprofen.


Q: Is Diclogen the same kind of medicine as naproxen?

Yes. Both Diclogen (diclofenac) and naproxen are chemically different compounds that belong to the same large class of medicines called Non-steroidal Anti-inflammatory Drugs (NSAIDs). They share a similar primary mechanism of action related to the inhibition of cyclooxygenase (COX) enzymes.


Q: Is Diclogen considered a strong pain reliever?

Diclogen’s active ingredient is a non-opioid medicine that is indicated for the symptomatic relief of pain and inflammation associated with approved conditions. Its anti-inflammatory and analgesic (pain-relieving) properties are described in medical literature, and it is indicated for the symptomatic relief of pain.


Q: What does the research say about Diclogen for arthritis pain?

The topical solution is formally indicated by regulatory bodies to relieve the signs and symptoms of osteoarthritis in specific joints, such as the knees. The active ingredient is also used in other formulations to help manage other types of arthritis, like rheumatoid arthritis.


Q: What is the evidence theme regarding Diclogen and pain relief?

The core theme described in official medical literature is that the active ingredient works by inhibiting the cyclooxygenase (COX) enzyme pathway. This action restricts the synthesis of prostaglandins, which are key cellular mediators that contribute to inflammation and pain signaling.


Q: Why is Diclogen sometimes used in combination with other medicines?

The active ingredient, diclofenac, is sometimes used alongside non-NSAID pain relievers such as acetaminophen (paracetamol) to provide additional types of pain relief. This is done because these other pain relievers work through different mechanisms in the body.


Q: Can Diclogen be taken for headaches or migraines?

The Diclogen topical solution is specifically indicated for the local pain of osteoarthritis in joints like the knee. However, a different oral formulation of the active ingredient (diclofenac potassium) is approved by regulatory bodies for the acute treatment of migraine attacks in adults.


Q: Are there different strengths of Diclogen available?

Yes, the topical solution formulation is officially available in different concentrations. These include a 1.5% w/w solution and a 2% w/w solution, which are prescribed with different dosing frequencies.


Q: Can Diclogen affect my blood pressure?

Yes. Official documents state that Nonsteroidal Anti-inflammatory Drugs (NSAIDs) can potentially cause new-onset hypertension or worsen existing high blood pressure. Regulatory guidance advises monitoring blood pressure during the initiation and course of NSAID therapy.


Q: Is it possible to become dependent on Diclogen?

Diclogen is a Non-steroidal Anti-inflammatory Drug (NSAID) and is not classified as an opioid or controlled substance. Official regulatory information does not associate the medicine with the potential for physical dependence or substance use disorder.


Q: Is Diclogen safe for older adults (seniors)?

Official documentation advises caution for older adults due to an inherent increased risk of serious adverse events associated with NSAIDs, particularly concerning the kidneys and heart. Some studies have investigated the tolerability of the topical formulation in patients aged 65 and older.


Q: What is the risk of an allergic reaction to Diclogen?

The medicine is contraindicated (prohibited) in anyone with a known history of severe allergic-type reactions to aspirin or other NSAIDs. The most common adverse events, however, are local application site reactions such as dermatitis, itching, and redness.


Q: Is it safe to take Diclogen while on birth control pills?

Official health guidance indicates that the active ingredient in Diclogen is not known to affect the effectiveness of hormonal contraceptives, including the combined or progestogen-only birth control pills.


Q: Is Diclogen approved for treating back pain?

The topical solution is formally indicated for the symptomatic treatment of osteoarthritis of the knee. While the active ingredient may be used in other formulations or studied for back pain, this is not the approved indication for the topical solution.


Q: Are there any known long-term effects of using Diclogen?

Long-term use of the NSAID class of medicines is associated with a rare, increased potential for serious systemic effects like cardiovascular or gastrointestinal events. Official guidance emphasizes using the medicine for the shortest duration necessary, although studies have evaluated the long-term tolerability of the topical gel for up to 52 weeks.

How should Diclogen be stored and disposed of?

How to Store and Dispose of Diclofenac Topical Solution

The storage and disposal of diclofenac topical solution must follow official regulatory requirements to ensure product integrity and safety.


Official Storage Conditions

The solution must be stored at Controlled Room Temperature, which is 20 C to 25 C (68 F to 77 F). It is mandatory to keep the product from freezing and to store it away from heat, sparks, and open flame due to the presence of flammable components. Keep the solution in its original container with the lid tightly closed.

Disposal and Safety

All medicines must be stored out of the sight and reach of children. Unused or expired solution must be disposed of in accordance with local regulations for pharmaceutical waste. To protect the environment, the solution should generally not be flushed down a toilet or poured down a drain.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Diclogen found in:

A-Z Index: